2023
DOI: 10.3390/pharmaceutics15051522
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Agent-Loaded Fibrous Scaffolds for Biomedical Applications

Abstract: Tissue engineering is a sophisticated field that involves the integration of various disciplines, such as clinical medicine, material science, and life science, to repair or regenerate damaged tissues and organs. To achieve the successful regeneration of damaged or diseased tissues, it is necessary to fabricate biomimetic scaffolds that provide structural support to the surrounding cells and tissues. Fibrous scaffolds loaded with therapeutic agents have shown considerable potential in tissue engineering. In th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 266 publications
0
1
0
Order By: Relevance
“…Moreover, the potential interactions between drug molecules and the printing process itself, such as exposure to high temperatures or shear forces, may impact the stability or activity of the therapeutic agents. Thus, further research is imperative to optimize the formulation and printing parameters to ensure the integrity and efficacy of the incorporated agents [98]. Moreover, the regulatory considerations and approval processes for 3D-printed drug delivery systems present formidable challenges.…”
Section: The Translation Of Bioprinting Technologies To Clinicalmentioning
confidence: 99%
“…Moreover, the potential interactions between drug molecules and the printing process itself, such as exposure to high temperatures or shear forces, may impact the stability or activity of the therapeutic agents. Thus, further research is imperative to optimize the formulation and printing parameters to ensure the integrity and efficacy of the incorporated agents [98]. Moreover, the regulatory considerations and approval processes for 3D-printed drug delivery systems present formidable challenges.…”
Section: The Translation Of Bioprinting Technologies To Clinicalmentioning
confidence: 99%